We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

674 hedge funds and large institutions have $39.7B invested in Allergan plc in 2014 Q2 according to their latest regulatory filings, with 103 funds opening new positions, 272 increasing their positions, 223 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more first-time investments, than exits

New positions opened: 103 | Existing positions closed: 52

77% more call options, than puts

Call options by funds: $1.11B | Put options by funds: $627M

22% more repeat investments, than reductions

Existing positions increased: 272 | Existing positions reduced: 223

19% more capital invested

Capital invested by funds: $33.3B → $39.7B (+$6.35B)

15% more funds holding in top 10

Funds holding in top 10: 7384 (+11)

7% more funds holding

Funds holding: 628674 (+46)

Holders
674
Holders Change
+46
Holders Change %
+7.32%
% of All Funds
19.37%
Holding in Top 10
84
Holding in Top 10 Change
+11
Holding in Top 10 Change %
+15.07%
% of All Funds
2.41%
New
103
Increased
272
Reduced
223
Closed
52
Calls
$1.11B
Puts
$627M
Net Calls
+$482M
Net Calls Change
+$56.9M
Name Holding Trade Value Shares
Change
Change in
Stake
MAA
126
Managed Account Advisors
New Jersey
$50.9M -$3.59M -17,344 -7%
LM
127
Litespeed Management
New York
$49M +$45.4M +219,483 New
KI
128
Kalmar Investments
Delaware
$48.6M -$20.7K -100 -0%
SAM
129
Steinberg Asset Management
New York
$46.8M -$8.69M -41,985 -17%
ZDA
130
Zweig-DiMenna Associates
New York
$46.7M +$22.9M +110,445 +112%
PPA
131
Parametric Portfolio Associates
Washington
$46.3M +$336K +1,624 +0.8%
TCM
132
Tekla Capital Management
Massachusetts
$45.9M
SIM
133
Sadoff Investment Management
Wisconsin
$45.7M -$2.15M -10,370 -5%
Swiss National Bank
134
Swiss National Bank
Switzerland
$42M -$26.9M -129,800 -41%
AC
135
Ascend Capital
California
$41.8M -$1.1M -5,320 -3%
Manulife (Manufacturers Life Insurance)
136
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$40.9M +$3.42M +16,494 +10%
TAL
137
TIG Advisors LLC
New York
$40.5M +$37.6M +181,479 New
Federated Hermes
138
Federated Hermes
Pennsylvania
$39.7M +$3.64M +17,588 +11%
RG
139
Redmile Group
California
$39.4M -$14.4M -69,700 -28%
State of Wisconsin Investment Board
140
State of Wisconsin Investment Board
Wisconsin
$39.4M -$1.02M -4,926 -3%
SCI
141
Seneca Capital Investments
New York
$38.8M +$13.3M +64,000 +58%
PCMF
142
Private Capital Management (Florida)
Florida
$38.4M -$554K -2,676 -2%
GMI
143
Greystone Managed Investments
Saskatchewan, Canada
$37.6M -$7.53M -36,350 -18%
Fiera Capital (Canada)
144
Fiera Capital (Canada)
Quebec, Canada
$36.8M -$3.6M -17,380 -10%
PP
145
PDT Partners
New York
$36.3M +$21.8M +105,176 +183%
CPM
146
Chesapeake Partners Management
Maryland
$35.6M -$2.09M -10,082 -6%
IGIM
147
I.G. Investment Management
Manitoba, Canada
$35.6M +$9.47M +45,718 +40%
Bank of Montreal
148
Bank of Montreal
Ontario, Canada
$35.2M +$8.92M +43,065 +37%
N
149
Nuveen
North Carolina
$34.9M +$4.4M +21,259 +16%
SGAM
150
Smith Group Asset Management
Texas
$31.6M -$4.24M -20,497 -13%

AGN Hedge Fund Activity: Q2 2014 in Review

674 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q2 2014, worth a combined $39.7B — up 19% from $33.3B a quarter earlier.

Buyers outnumbered sellers: 103 funds opened new AGN positions and 52 closed out — a net gain of 51 holders — while 272 added to existing stakes and 223 trimmed.

The largest buyer was Jana Partners, adding an estimated $363M. The largest seller was York Capital Management Global Advisors, exiting entirely with an estimated $198M sold.

  • 674 institutional investors held Allergan plc (AGN) as of Q2 2014, up from 628 in Q1 2014.
  • Funds reported $39.7B of Allergan plc stock for Q2 2014, up 19% quarter-over-quarter.
  • 103 funds opened new Allergan plc positions in Q2 2014 and 52 closed out, a net change of +51 holders.
  • The largest Allergan plc buyer in Q2 2014 was Jana Partners, an estimated $363M added.
  • The largest Allergan plc seller in Q2 2014 was York Capital Management Global Advisors, an estimated $198M sold.

Based on aggregated 13F filings for Q2 2014.